DiscoverGovernment Accountability Office (GAO) Podcast: Watchdog ReportFDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels
FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

Update: 2024-11-13
Share

Description

The Food and Drug Administration (FDA) inspects drug manufacturers here and overseas to ensure the safety and quality of drug sold in the United States. But FDA paused many of its in-person inspection efforts during COVID-19 because of travel…
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

Government Accountability Office